Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sabin-strain Inactivated Poliovirus Vaccine (Vero cell) Consistency and Sequential Immunization Study in 2-Month-Old Infants
CTR20182558Phase 3Active
- Sponsor
- Beijing Tiantan Biological
- Start
- Jan 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Beijing Tiantan Biological. Started Jan 2019; status: active.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on CTR20182558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182558.